Menopause. Menopausal and female climacteric states
Conditions
Interventions
Intervention 1: Premarin group: The patients in this group were treated with vaginal premarin 0.625% for three months.
Royal Jelly group: The patients in this group were treated with vaginal Ro
Treatment - Drugs
Premarin group: The patients in this group were treated with vaginal premarin 0.625% for three months.
Royal Jelly group: The patients in this group were treated with vaginal Royal jelly 15% i
Lubricant group: The patients in this group were treated with vaginal lubricant gel for three months.
Sponsors
Shahrekord University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
50 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Menopausal women; aged between 50 to 65 years; married women; diagnosis of vaginal atrophy Exclusion criteria: Diabetes mellitus; history of endometrial cancer; history of breast cancer; cystocele; hormone therapy; sensitivity to honey products or premarin
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Vaginal atrophy. Timepoint: At the beginning and end of the study. Method of measurement: Pap-Smear test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Fatemeh Seiedy
Shahrekord University of Medical Sciences
Outcome results
None listed